Products that put patients first
The high purity of our PureActives® API - higher than any other equivalent product in the market - is a characteristic which is successfully used as a unique selling point by our customers. The reduced toxicity, owing to the absence of most residual solvents, is valued by doctors and patients alike.
Our products also taste better due to the absence of most residual solvents. Suspensions and syrups often need to cover the dominant smell and taste of residual solvents, for example, in the API. Formulations based on PureActives® are odourless and tasteless and therefore valued over chemically produced ingredients by customers, doctors and patients.
The outstanding stability of PureActives® API gives formulators an excellent starting point for a formulation process that will result in stable dosage forms. Of course, there are many other important factors to control, such as the formulation process, handling and packaging.
Antimicrobial Resistance (AMR)
As well as their proven sustainability advantages, our PureActives® processes support our wider efforts to combat the growing problem of antimicrobial resistance, or AMR. Like our wider production processes, our enzymatic technology is supported by dedicated wastewater treatment plants which operate 24/7 throughout the year, with effluents regularly sampled for antimicrobial activity to safeguard the environment.